drugset / Trial / NCT01992094
Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Evaluate safety and immunogenicity of three influenza vaccines in adults 18 years of age and above.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QIVc | Vaccine | — | — |
| Comparator | TIV1c | Vaccine | — | — |
| Comparator | TIV2c | Vaccine | — | — |